Biotech
IRVINE, CA: ISTA Reminds Investors of Its Upcoming 2012 Guidance and Pipeline Update Webcast/Conference Call Scheduled on January 4, 2012 ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 01/03/12 -- Ceapro Inc. (TSX VENTURE: CZO) today announced that holders of $370,000 of the convertible debentures due December 31, 2011 have elected to convert t ...
SEATTLE, WA: Ronald A. Martell Named Chairman of the Board, Steps Down as CEO ...
BOTHELL, WA: Company Will Update on Recent Licensing Transaction and Near-Term Value Drivers ...
PRINCETON, NJ: On Track to Submit NDA for New Low-Dose Contraceptive Patch in Q1 2012 ...
WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 12/30/11 -- (NASDAQ: BASI) today announced that its board of directors unanimously elected Seth Hamot as a director, effective December 28, 2011. "We are p ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 12/29/11 -- Mr. Robert S. Pollock ("Pollock"), 130 King Street West, Suite 2110, Toronto, Ontario M5X 1B1 announces that, on December 19, 2011, he acqui ...
SEATTLE, WA: SEATTLE, WA -- (Marketwire) -- 12/29/11 -- Pacific Biomarkers (PBI), a Seattle, WA-based limited liability company that provides premier biomarker and specialty efficacy testing services to the drug ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/29/11 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the year en ...
TUSTIN, CA: Preliminary Data From Phase II Study Shows Antiviral Activity and Positive Safety Profile at Both Bavituximab Doses Evaluated; Supporting Further Dosing and Combination Studies; Company to Seek Collab ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 12/27/11 -- (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds in onco ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 12/23/11 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tech ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 12/23/11 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tech ...
BOTHELL, WA and AUSTIN, TX: Mirna Therapeutics Will Develop Oncology-Focused Compounds Utilizing Their Proprietary microRNAs Combined With Marina Biotech's Novel SMARTICLES(R) Liposomal Delivery Technology ...
LONDON, ONTARIO: Company Plans to Initiate Patient Enrollment in a Phase I/II Clinical Trial and Participate With a Leading Research Center in Grant Submissions to Explore Further Applications for the Cell Pouch(TM) S ...
LEUVEN, BELGIUM and MADRID, SPAIN: LEUVEN, BELGIUM and MADRID, SPAIN -- (Marketwire) -- 12/23/11 -- TiGenix (EURONEXT BRUSSELS: TIG), a leading biopharmaceutical company that commercializes and develops cell therapies, announced today ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 12/22/11 -- Biotonix (2010) Inc. ("Biotonix") (TSX VENTURE: BTX), a company listed on the TSX Venture Exchange, is pleased to announce that it has enter ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 12/22/11 -- Helix BioPharma Corp (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment o ...
PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 12/22/11 -- The Medicines Company (NASDAQ: MDCO) will present at the 30th Annual J.P. Morgan Healthcare Conference on Monday, January 9th, in San Francisco, CA begin ...
DENVER, CO: Omni Bio Pharmaceutical, Inc. Obtains Patent for Diabetes Treatment Through Licensing Partner, Bio Holding, Inc. ...
